Saskatchewan MS sufferer awaits spot in 'liberation treatment' study
www.thestarphoenix.com
Andrew Dahlen will soon learn if he will be Saskatchewan’s first patient to participate in a clinical trial for a controversial multiple sclerosis treatment.